Keywords: Muscle, MSK
Motivation: Pompe disease is an autosomal recessive metabolic disorder that is characterized by a deficiency of the lysosomal enzyme alpha-glucosidase (GAA), resulting in massive glycogen deposition in muscle. It helps to develop advanced CEST MRI to help manage Pompe disease.
Goal(s): We aimed to develop and test quantitative glycogen CEST (GlyCEST) MRI for non-invasive monitoring of disease progression in GAAKO mice.
Approach: We performed longitudinal GlyCEST scans in wild-type and GAAKO mice and tested the correlation between QUASS-boosted quantitative glycogen MRI with glycogen assay.
Results: GlyCEST MRI provides a surrogate MRI biomarker that significantly correlates with the muscle glycogen biochemical assay.
Impact: GlyCEST is promising to monitor glycogen levels in Pompe mice in real-time non-invasively and is potentially valuable for monitoring treatment response and ultimately clinical translation.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords